Jan 14, 2020 Announcements and research updates from the The Women's Alzheimer's Movement - WAM and UCI MIND Initiative to fund sex disparities in #Alzheimers research at University of California, Irvine. Congratulations to Mathew Blurton-Jones, PhD and Sunil Gandhi, PhD from the UCI School of Biological Sciences and Anshu Agrawal, PhD from the UCI School of Medicine, recipients of seed funding grants made possible by WAM Founder Maria Shriver and the Living Legacy Foundation led by VP and Executive Director Alisha Ballard.
Read More
ASK THE DOC! UCI MIND Facebook LIVE Video Series This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. When will we have an effective treatment for Alzheimer's disease? About the Speaker: Joshua Grill, PhD, is an Associate Professor of Psychiatry & Human Behavior and Neurobiology & Behavior at UCI. He serves…
Read More
Contributed by Keith Swayne, UCI MIND Leadership Council Outstanding Philanthropist Keith Swayne, center, with Honorary Chairs and 2019 Legacy award honorees for Ueberroth Family Foundation Ginny Ueberroth, left, and Vicki Booth, right.(Tony Lattimore and Carla Rhea) - Daily Pilot It is humbling to be recognized as Philanthropist of the Year, particularly when I think about the many individuals who are working to make a difference in the world. The OC National Philanthropy Day event brought together Orange County philanthropists and non-profit organizations to celebrate our shared vision of improving our community. This is what drives me. I wish to use…
Read More
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 11: "What is the link between Down syndrome and Alzheimer's?" This month, we’re joined by Ira Lott, MD, Professor Emeritus of Pediatrics and Neurology at UCI School of Medicine. Dr. Lott is…
Read More
Contributed by Joshua Grill, PhD On Thursday, December 5, attendees at the Clinical Trials in Alzheimer’s Disease (CTAD) Conference heard more from Biogen about its recently resurrected drug, aducanumab (see previous Blog). New data were presented that were consistent with what had previously been shared. Biogen claims that a single positive Phase 3 trial of aducanumab and a secondary analysis of data from a second, negative Phase 3 trial suggest a benefit among patients receiving the highest dose for the full duration of the study (18 months). In both cases, high dose aducanumab appeared to slow the rate of disease…
Read More
